Patricia Semedo

Patricia Semedo

Auto-generated profile, based on publicly available information

Patricia Semedo

Laboratory of Experimental and Clinical Immunology, Nephrology Division, Federal University of São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2009 in Stem Cells
Verified
Journal Article
Open access
PDF file
PSPatricia Semedo
Patricia Semedo
MCMatheus Correa-Costa
Matheus Correa-Costa
MCMarcos Antonio Cenedeze
Marcos Antonio Cenedeze
DMDenise Maria Avancini Costa Malheiros
Denise Maria Avancini Costa Malheiros
MRMarlene Antonia dos Reis
Marlene Antonia dos Reis
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara
Mesenchymal stem cells (MSCs) have regenerative properties in acute kidney injury, but their role in chronic kidney diseases is still unknown. More specifically, it is not known whether MSCs halt fibrosis. The purpose of this work was to investigate the role of MSCs in fibrogenesis using a model of chronic renal failure. MSCs were obtained from the tibias and femurs of male Wistar-EPM rats. Female Wistar rats were subjected to the remnant model, and 2|×|105 MSCs were intravenously administrated to each rat every other week for 8 weeks or only once and followed for 12 weeks. SRY gene expression was observed in female rats treated with male MSCs, and immune localization of CD73+CD90+ cells at 8 weeks was also assessed. Serum and urine analyses showed an amelioration of functional parameters in MSC-treated animals at 8 weeks, but not at 12 weeks. Masson's trichrome and Sirius red staining demonstrated reduced levels of fibrosis in MSC-treated animals. These results were corroborated by reduced vimentin, type I collagen, transforming growth factor β, fibroblast specific protein 1 (FSP-1), monocyte chemoattractant protein 1, and Smad3 mRNA expression and α smooth muscle actin and FSP-1 protein expression. Renal interleukin (IL)-6 and tumor necrosis factor α mRNA expression levels were significantly decreased after MSC treatment, whereas IL-4 and IL-10 expression levels were increased. All serum cytokine expression levels were decreased in MSC-treated animals. Taken together, these results suggested that MSC therapy can indeed modulate the inflammatory response that follows the initial phase of a chronic renal injury. The immunosuppressive and remodeling properties of MSCs may be involved in the decreased fibrosis in the kidney. Disclosure of potential conflicts of interest is found at the end of this article.

1 January 2011 in Neurology Research International
Verified
Journal Article
Open access
PDF file
LGLayla T. Galindo
Layla T. Galindo
TFThais R. M. Filippo
Thais R. M. Filippo
PSPatricia Semedo
Patricia Semedo
CACarolina B. Ariza
Carolina B. Ariza
CMCaroline M. Moreira
Caroline M. Moreira
MPMarimelia Porcionatto
Marimelia Porcionatto
Therapy with mesenchymal stem cells (MSCs) has showed to be promising due to its immunomodulatory function. Traumatic brain injury (TBI) triggers immune response and release of inflammatory mediators, mainly cytokines, by glial cells creating a hostile microenvironment for endogenous neural stem cells (NSCs). We investigated the effects of factors secreted by MSCs on NSCin vitroand analyzed cytokines expressionin vitroin a TBI model. Ourin vitroresults show that MSC-secreted factors increase NSC proliferation and induce higher expression of GFAP, indicating a tendency toward differentiation into astrocytes.In vivoexperiments showed that MSC injection at an acute model of brain injury diminishes a broad profile of cytokines in the tissue, suggesting that MSC-secreted factors may modulate the inflammation at the injury site, which may be of interest to the development of a favorable microenvironment for endogenous NSC and consequently to repair the injured tissue.

1 June 2009 in International Immunopharmacology
Verified
Journal Article
Closed access
PSPatricia Semedo
Patricia Semedo
CPCarolina G. Palasio
Carolina G. Palasio
COCassiano D. Oliveira
Cassiano D. Oliveira
CFCarla Q. Feitoza
Carla Q. Feitoza
GGGiselle M. Gonçalves
Giselle M. Gonçalves
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara

1 March 2007 in Transplantation Proceedings
Verified
Journal Article
Closed access
PSP. Semedo
P. Semedo
PWP.M. Wang
P.M. Wang
TAT.H. Andreucci
T.H. Andreucci
MCM.A. Cenedeze
M.A. Cenedeze
VTV.P.A. Teixeira
V.P.A. Teixeira
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara

14 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MCMatheus Correa-Costa
Matheus Correa-Costa
TBTarcio Teodoro Braga
Tarcio Teodoro Braga
PSPatricia Semedo
Patricia Semedo
CHCaroline Yuri Hayashida
Caroline Yuri Hayashida
LBLuiz Roberto Grassmann Bechara
Luiz Roberto Grassmann Bechara
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara
Tubule-interstitial nephritis (TIN) results in decreased renal function and interstitial inflammation, which ultimately leads to fibrosis. Excessive adenine intake can cause TIN because xanthine dehydrogenase (XDH) can convert this purine into an insoluble compound, which precipitates in the tubuli. Innate immune sensors, such as Toll-like receptors (TLR) and inflammasome complex, play a crucial role in the initiation of inflammation. The aim of this study was to evaluate the roles of TLR-2 and -4, Myd88 and inflammasome complex in an experimental model of TIN. Here, we show that wild-type (WT) mice fed adenine-enriched food exhibited significant renal dysfunction and enhanced cellular infiltration accompanied by collagen deposition. They also presented higher gene and protein expression of pro-inflammatory cytokines. In contrast, TLR-2, -4, MyD88, ASC and Caspase-1 KO mice showed renoprotection associated with expression of inflammatory molecules at levels comparable to controls. Furthermore, treatment of WT animals with allopurinol, an XDH inhibitor, led to reduced levels of uric acid, oxidative stress, collagen deposition and a downregulation of the NF-kB signaling pathway. We concluded that MyD88 signaling and inflammasome participate in the development of TIN. Furthermore, inhibition of XDH seems to be a promising way to therapeutically target the developing inflammatory process.

15 April 2012 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
ASAna Carolina C. Pessoa de Souza
Ana Carolina C. Pessoa de Souza
RVRildo Aparecido Volpini
Rildo Aparecido Volpini
MSMaria Heloísa Shimizu
Maria Heloísa Shimizu
TSTalita Rojas Sanches
Talita Rojas Sanches
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara
LALúcia Conceição Andrade
Lúcia Conceição Andrade
The pathophysiology of sepsis involves complex cytokine and inflammatory mediator networks, a mechanism to which NF-κB activation is central. Downregulation of endothelial nitric oxide synthase (eNOS) contributes to sepsis-induced endothelial dysfunction. Erythropoietin (EPO) has emerged as a major tissue-protective cytokine in the setting of stress. We investigated the role of EPO in sepsis-related acute kidney injury using a cecal ligation and puncture (CLP) model. Wistar rats were divided into three primary groups: control (sham-operated); CLP; and CLP+EPO. EPO (4,000 IU/kg body wt ip) was administered 24 and 1 h before CLP. Another group of rats received N-nitro-l-arginine methyl ester (l-NAME) simultaneously with EPO administration (CLP+EPO+l-NAME). A fifth group (CLP+EPOtreat) received EPO at 1 and 4 h after CLP. At 48 h postprocedure, CLP+EPO rats presented significantly higher inulin clearance than did CLP and CLP+EPO+l-NAME rats; hematocrit levels, mean arterial pressure, and metabolic balance remained unchanged in the CLP+EPO rats; and inulin clearance was significantly higher in CLP+EPOtreat rats than in CLP rats. At 48 h after CLP, creatinine clearance was significantly higher in the CLP+EPO rats than in the CLP rats. In renal tissue, pre-CLP EPO administration prevented the sepsis-induced increase in macrophage infiltration, as well as preserving eNOS expression, EPO receptor (EpoR) expression, IKK-α activation, NF-κB activation, and inflammatory cytokine levels, thereby increasing survival. We conclude that this protection, which appears to be dependent on EpoR activation and on eNOS expression, is attributable, in part, to inhibition of the inflammatory response via NF-κB downregulation.